Literature DB >> 7060030

Amyloid A in systemic amyloidosis associated with cancer.

G Husby, G Marhaug, K Sletten.   

Abstract

Amyloid fibrils from two cases of cancer-associated, systemic amyloidosis with renal cell carcinoma and mesothelioma as the respective underlying disorders were studied. The immunochemical studies suggested strongly that amyloid A comprised a principal fibril component in both cases of cancer-associated amyloidosis. This was definitively proven by amino acid sequence analyses, which revealed structural homology between a purified subcomponent of the amyloid fibrils from both of the two cases of cancer-associated amyloidosis and previously sequenced amyloid A proteins. The chemical composition of the amyloid fibrils from systemic amyloidosis associated with cancer thus corresponded to that seen in amyloidosis reactive to inflammatory diseases and Hodgkin's disease. Amyloid proteins of immunoglobulin light chain type, which are found associated with myelomatosis, macroglobulinemia, and idiopathic (primary) amyloidosis, were not found in the two amyloid preparations. Renal cell carcinoma appears to be an effective stimulator of amyloid formation, while only one case of amyloidosis associated with mesothelioma has been reported previously.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060030

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation.

Authors:  Sanket Patke; Ronak Maheshwari; Jeffrey Litt; Saipraveen Srinivasan; J Javier Aguilera; Wilfredo Colón; Ravi S Kane
Journal:  Biochemistry       Date:  2012-03-26       Impact factor: 3.162

2.  Systemic amyloid associated with carcinoma of the bronchus.

Authors:  I Richmond; P S Hasleton; S Samadian
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

Review 3.  Reactive (secondary) amyloidosis and its pathogenesis.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

4.  Monoclonal hybridoma antibodies to human amyloid related protein SAA.

Authors:  G Marhaug; G Gaudernack; B Bogen; G Husby
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

Review 5.  Serum amyloid A: an acute-phase protein involved in tumour pathogenesis.

Authors:  E Malle; S Sodin-Semrl; A Kovacevic
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

Review 6.  Serum amyloid A, a host-derived DAMP in pregnancy?

Authors:  Yi-Kai Lin; Ping Zhu; Wang-Sheng Wang; Kang Sun
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

7.  Multiple Endocrine Neoplasms in a Patient with AL Amyloidosis-Associated Plasma Cell Dyscrasia.

Authors:  Kunihiko Seki; Shingo Wakatsuki; Kazuo Hizawa; Tadashi Hasegawa; Yuichi Fujinaka; Hiroshi Yokogoshi; Shiro Saito; Toshiaki Sano
Journal:  Endocr Pathol       Date:  1997       Impact factor: 4.056

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.